BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17132204)

  • 1. Formulation and evaluation of nimodipine-loaded lipid microspheres.
    Yu J; He HB; Tang X
    J Pharm Pharmacol; 2006 Nov; 58(11):1429-35. PubMed ID: 17132204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation, preparation and evaluation of flunarizine-loaded lipid microspheres.
    Wang YJ; Wang J; Zhang HY; He HB; Tang X
    J Pharm Pharmacol; 2007 Mar; 59(3):351-7. PubMed ID: 17331337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lipid microsphere vehicle for vinorelbine: Stability, safety and pharmacokinetics.
    Zhang HY; Tang X; Li HY; Liu XL
    Int J Pharm; 2008 Feb; 348(1-2):70-9. PubMed ID: 17719191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and pharmacokinetics of nimodipine-loaded liposomes.
    Wang Z; Deng Y; Zhang X; Wang T; Wu F
    J Pharm Pharmacol; 2006 Sep; 58(9):1289-94. PubMed ID: 16945189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and evaluation of less-painful clarithromycin lipid microspheres.
    LingHao Q; Wei L
    Arch Pharm Res; 2007 Oct; 30(10):1336-43. PubMed ID: 18038913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain.
    Zhang Q; Jiang X; Jiang W; Lu W; Su L; Shi Z
    Int J Pharm; 2004 May; 275(1-2):85-96. PubMed ID: 15081140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis.
    Ye J; Wang Q; Zhou X; Zhang N
    Int J Pharm; 2008 Mar; 352(1-2):273-9. PubMed ID: 18054182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of an intravenous injectable nimodipine nanosuspension in mice.
    Xiong R; Lu W; Yue P; Xu R; Li J; Chen T; Wang P
    J Pharm Pharmacol; 2008 Sep; 60(9):1155-9. PubMed ID: 18718118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of intravenously injectable nimodipine nanosuspension.
    Xiong R; Lu W; Li J; Wang P; Xu R; Chen T
    Int J Pharm; 2008 Feb; 350(1-2):338-43. PubMed ID: 17920794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and evaluation of Nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system.
    Chalikwar SS; Belgamwar VS; Talele VR; Surana SJ; Patil MU
    Colloids Surf B Biointerfaces; 2012 Sep; 97():109-16. PubMed ID: 22609590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of both olfactory and systemic pathways for brain targeting of nimodipine-loaded lipo-pluronics micelles: in vitro characterization and in vivo biodistribution study after intranasal and intravenous delivery.
    Rashed HM; Shamma RN; Basalious EB
    Drug Deliv; 2016 Nov; 24(1):181-187. PubMed ID: 28156162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nimodipine-loaded mixed micelles: formulation, compatibility, pharmacokinetics, and vascular irritability study.
    Song X; Jiang Y; Ren C; Sun X; Zhang Q; Gong T; Zhang Z
    Int J Nanomedicine; 2012; 7():3689-99. PubMed ID: 22888228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation and in vitro and in vivo evaluation of etoposide submicro-emulsion for intravenous injection].
    Tian LL; Tang X; He HB; Wang J
    Yao Xue Xue Bao; 2007 Aug; 42(8):892-7. PubMed ID: 17944242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
    Liu J; Gong T; Wang C; Zhong Z; Zhang Z
    Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A less irritant norcantharidin lipid microspheres: formulation and drug distribution.
    Lixin W; Haibing H; Xing T; Ruiying S; Dawei C
    Int J Pharm; 2006 Oct; 323(1-2):161-7. PubMed ID: 16828998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of N(3)-O-toluyl-fluorouracil-loaded liposomes.
    Sun W; Zhang N; Li A; Zou W; Xu W
    Int J Pharm; 2008 Apr; 353(1-2):243-50. PubMed ID: 18155370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and thermal sterile stability of a less painful intravenous clarithromycin emulsion containing vitamin E.
    Lu Y; Wang Y; Tang X
    Int J Pharm; 2008 Jan; 346(1-2):47-56. PubMed ID: 17640833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preparation and evaluation of clarithromycin emulsion for injection].
    Qin LH; Tang X
    Yao Xue Xue Bao; 2006 Oct; 41(10):945-9. PubMed ID: 17184111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted delivery of levofloxacin-liposomes for the treatment of pulmonary inflammation.
    Zhang X; Sun P; Bi R; Wang J; Zhang N; Huang G
    J Drug Target; 2009 Jun; 17(5):399-407. PubMed ID: 19263265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on differences of pharmacokinetic behavior and tissue distribution of nimodipine and its two enantiomers in rats using achiral and chiral liquid chromatography.
    He LC; Wang SC
    Yao Xue Xue Bao; 2003 Aug; 38(8):603-8. PubMed ID: 14628452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.